150 related articles for article (PubMed ID: 10231142)
21. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate.
Miodosky M; Abdul-Hai A; Tsirigotis P; Or R; Bitan M; Resnick IB; Gesundheit B; Zilberman I; Ioffe L; Leubovic A; Slavin S; Shapira MY
Bone Marrow Transplant; 2006 Oct; 38(7):507-11. PubMed ID: 16921402
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
Bone Marrow Transplant; 2001 Apr; 27(7):727-30. PubMed ID: 11360113
[TBL] [Abstract][Full Text] [Related]
23. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
24. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm.
Leung AY; Yuen KY; Kwong YL
Bone Marrow Transplant; 2005 Dec; 36(11):929-37. PubMed ID: 16184185
[TBL] [Abstract][Full Text] [Related]
25. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
26. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation.
Mori Y; Miyamoto T; Kato K; Kamezaki K; Kuriyama T; Oku S; Takenaka K; Iwasaki H; Harada N; Shiratsuchi M; Abe Y; Nagafuji K; Teshima T; Akashi K
Biol Blood Marrow Transplant; 2012 Mar; 18(3):458-65. PubMed ID: 21810401
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Uberti JP; Ayash L; Braun T; Reynolds C; Silver S; Ratanatharathorn V
Bone Marrow Transplant; 2004 Sep; 34(5):425-31. PubMed ID: 15273705
[TBL] [Abstract][Full Text] [Related]
28. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
[TBL] [Abstract][Full Text] [Related]
29. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
30. Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients.
Choi IC; Fung PC; Leung AY; Lie AK; Liang R
Haematologica; 2001 Sep; 86(9):972-6. PubMed ID: 11532626
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Schetelig J; Kröger N; Held TK; Thiede C; Krusch A; Zabelina T; Dubiel M; Rick O; Bornhäuser M; Ehninger G; Zander AR; Siegert W
Haematologica; 2002 Mar; 87(3):299-305. PubMed ID: 11869943
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for severe hemorrhagic cystitis following BMT.
Seber A; Shu XO; Defor T; Sencer S; Ramsay N
Bone Marrow Transplant; 1999 Jan; 23(1):35-40. PubMed ID: 10037048
[TBL] [Abstract][Full Text] [Related]
34. Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis.
Anoop P; Shaw BE; Riley U; Ethell ME; Taj M; Lancaster DL; Atra A; Saso R; Littlewood S; Mohammed K; Davies F; Treleaven J; Morgan GJ; Potter MN
Hematology; 2011 Jul; 16(4):213-20. PubMed ID: 21756537
[TBL] [Abstract][Full Text] [Related]
35. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation for beta-thalassemia in children].
Yin WF; Pei FY; Wu XD; Liu SX; He YL; Liao JY; Li N; Chen GY; Feng XQ; Li CF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):838-41. PubMed ID: 20423861
[TBL] [Abstract][Full Text] [Related]
37. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
[TBL] [Abstract][Full Text] [Related]
38. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
[TBL] [Abstract][Full Text] [Related]
39. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
Foss FM
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
[TBL] [Abstract][Full Text] [Related]
40. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
